Article
Monocyte-derived macrophages for treatment of cerebral palsy: a study of 57 cases
2018-03-01
Abstract excerpt
Objective: Cell-based technologies are considered to be a new approach for the treatment of cerebral palsy (CP). Given the potent anti-inflammatory activity and high regenerative potential of M2 macrophages, these cells may be a promising source for cell transplantation. To evaluate the safety and efficacy of autologous M2 macrophages, we performed an open-label, Phase I/II, non-controlled clinical trial in childr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 684c16b5-658c-5329-86eb-54eb35e2dd7d
- DOI
- 10.2147/jn.s158843
